| 1 |
Rathod S, Chavan P, Mahuli D, Rochlani S, Shinde S, Pawar S, Choudhari P, Dhavale R, Mudalkar P, Tamboli F. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach. J Mol Model 2023;29:113. [DOI: 10.1007/s00894-023-05521-8] [Reference Citation Analysis]
|
| 2 |
Karademir M. Effect of P-glycoprotein Inhibition on Temozolomide Chemosensitivity on the Neuroblastoma Cell Line Sh-sy5y.. [DOI: 10.21203/rs.3.rs-2603170/v1] [Reference Citation Analysis]
|
| 3 |
Tezcan O, Elshafei AS, Benderski K, Rama E, Wagner M, Moeckel D, Pola R, Pechar M, Etrych T, von Stillfried S, Kiessling F, Weiskirchen R, Meurer S, Lammers T. Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer. J Control Release 2023;354:784-93. [PMID: 36599395 DOI: 10.1016/j.jconrel.2022.12.056] [Reference Citation Analysis]
|
| 4 |
Nielsen RB, Holm R, Pijpers I, Snoeys J, Nielsen UG, Nielsen CU. Combinational Inhibition of P-Glycoprotein-Mediated Etoposide Transport by Zosuquidar and Polysorbate 20. Pharmaceutics 2023;15. [PMID: 36678911 DOI: 10.3390/pharmaceutics15010283] [Reference Citation Analysis]
|
| 5 |
Fedotcheva TA, Shimanovsky NL. Pharmacological Strategies for Overcoming Multidrug Resistance to Chemotherapy. Pharm Chem J 2023;56:1307-13. [PMID: 36683825 DOI: 10.1007/s11094-023-02790-8] [Reference Citation Analysis]
|
| 6 |
Ashique S, De Rubis G, Sirohi E, Mishra N, Rihan M, Garg A, Reyes R, Manandhar B, Bhatt S, Jha NK, Singh TG, Gupta G, Singh SK, Chellappan DK, Paudel KR, Hansbro PM, Oliver BG, Dua K. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chemico-Biological Interactions 2022;368:110231. [DOI: 10.1016/j.cbi.2022.110231] [Reference Citation Analysis]
|
| 7 |
Rzepka Z, Bębenek E, Chrobak E, Wrześniok D. Synthesis and Anticancer Activity of Indole-Functionalized Derivatives of Betulin. Pharmaceutics 2022;14:2372. [DOI: 10.3390/pharmaceutics14112372] [Reference Citation Analysis]
|
| 8 |
Duarte D, Nunes M, Ricardo S, Vale N. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action. Biomolecules 2022;12. [PMID: 36291699 DOI: 10.3390/biom12101490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Verma H, Narendra G, Raju B, Singh PK, Silakari O. Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00117] [Reference Citation Analysis]
|
